Skip to main content
$36.35 -$2.93 (-7.5%)

04:00 PM EST on 01/27/22

Cryoport, Inc. (NASDAQ:CYRX)

CAPS Rating: No stars

Cryoport, Inc., a life sciences services company, provides temperature-controlled logistics solutions in the Americas, Europe, the Middle East, Africa, and the Asia Pacific.

Current Price $36.35 Mkt Cap $1.9B
Open $39.97 P/E Ratio 0.00
Prev. Close $36.35 Div. (Yield) $0.00 (0.0%)
Daily Range $36.13 - $40.60 Volume 736,721
52-Wk Range $36.13 - $86.30 Avg. Daily Vol. 508,472

Caps

How do you think NASDAQ:CYRX will perform against the market?

Add Stock to CAPS Watchlist

All Players

2 Outperform
0 Underperform
 

All-Star Players

0 Outperform
0 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQ:CYRX Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

Top Bull Pitch

There are no pitches that meet the Top Bull criteria. Explain

If this upsets you, start recommending pitches below!

Top Bear Pitch

There are no pitches that meet the Top Bear criteria. Explain

If this upsets you, start recommending pitches below!

NASDAQ:CYRX VS S&P 500 (SPY)

NASDAQ:CYRX Summary

Recent Community Commentary

Read the most recent pitches from players about CYRX.

Recs

0
Member Avatar LAG20 (< 20) Submitted: 10/22/2021 9:06:21 AM : Outperform Start Price: $75.23 NASDAQ:CYRX Score: -46.69

Temperature-controlled supply-chain support for biosciences industry. Increasing need with vaccines, gene therapies, etc.

Leaderboard

Find the members with the highest scoring picks in CYRX.

Score Leader

WinyahBayInv

WinyahBayInv (75.31) Score: +2.79

The Score Leader is the player with the highest score across all their picks in CYRX.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
sneeves < 20 8/19/2021 Outperform 5Y $55.44 -34.43% -1.76% -32.67 0 Comment
LAG20 < 20 10/22/2021 Outperform 5Y $75.23 -51.68% -4.99% -46.69 1 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for CYRX.